We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Scancell Holdings Plc | SCLP | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -1.10 | -13.02% | 7.35 | 15:05:28 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 8.45 | 7.25 | 8.45 | 8.45 |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
| Top Posts |
|---|
Posted at 24/3/2025 14:26 by 2tyke Exactly as expected....SCLP testing the support at 7.65p. A long wick forming as bulls try and stem the big drop that would almost certainly happen below 7.6p.As always...only the technical expert on this bb calls it correctly. |
Posted at 23/3/2025 12:05 by inanaco is this True Ivy ... 2021.At my maximum I held between 700-750k in SCLP but that position alters depending on news or how I see the share price moving. |
Posted at 06/3/2025 10:32 by the real lozan Down the line -Many months ago, I raised thw question... amid the usual ridicule, of ......... which 'expenditure' would PROVE to be of more 'value' = My 'LOGS' or SCLP shares ??? As winter fades , where are we ??? On one hand, the logs are gone SCLP shares are less than half they cost One could say - YES BUT "I still own shares" = A LOSS = NO BENEFIT An Alternative view, is that I have had the BENEFIT from the heat over the winter for which the expenditure was intended = A BENEFIT . Probably why WE ALL have not been 'subjected to' the EGO trHYPE of late. . Just an Alternative View |
Posted at 05/2/2025 12:40 by inanaco just read these two posts 4 hrs apart ...................emptyend Posted in: SCLP Posts: 1,036 Price: 9.56 No Opinion RE: Proactive Interview30 Jan 2025 10:20 Loading up is the right course, roses. Some of those complaining also say they have been selling today so, by rights (and assuming they are honest 😬) we should be hearing a lot less from them in future! 👍 I did the same on the dip last year, to slightly below the current levels. We now know that pivotal news on both main products is due in the middle of this year - so I continue not to rule out a bid for the whole company as that point approaches, especially if at least one of the GenMab deals seems likely to generate further milestone payments, as indicated in the results. emptyend Posted in: SCLP Posts: 1,036 Price: 9.66 No Opinion RE: Interims . . .30 Jan 2025 07:35 IMO these snippets (which I had also noted) are pointing towards partnering for the registration trial of iSCIB1+. Whilst I agree dilution is a risk, remember that a Board decision to dilute shareholders would potentially dilute everyone around the table - and is only likely to be taken if both Vulpes and Redmile stand their corner. partnering continues to be more likely though, I think, the board would have a clear bottom line on the terms of such an agreement and would potentially be prepared to go it alone. Personally I think there will be a partnering deal announced in Q3. More straws in the wind from the analysts call, I suspect. |
Posted at 02/2/2025 18:11 by inanaco inanacoPosted in: SCLP Posts: 33,092 Price: 11.10 No Opinion RE: Sclp8 Sep 2020 19:15 Its an exciting time ........... i would rather spend it predicting the outcome of the science .... and back my hunch . than making all sorts of waffle about risk that those blabbering about it don't have a clue how to evaluate it .. |
Posted at 01/2/2025 19:58 by inanaco and just to repeat your postIvyspivey - 31 Jan 2025 - 11:56:49 - 16927 of 17153 Scancell - Pot of Gold or POS? - SCLP You know perfectly well that we were both referring to an Infectious disease Vax platform not oncology. Please let me know where the status of SCLP ID Vax Platform is now.? you clearly are describing 2 platforms Cancer and infectious disease |
Posted at 01/2/2025 14:30 by inanaco tell you why nobody asks you a question Ivy ...you claim so much but deliver so little an example post .... one that is ruled by stupidity Ivyspivey - 31 Jan 2025 - 11:56:49 - 16927 of 17121 Scancell - Pot of Gold or POS? - SCLP You know perfectly well that we were both referring to an Infectious disease Vax platform not oncology. Please let me know where the status of SCLP ID Vax Platform is now.? |
Posted at 31/1/2025 19:45 by 2tyke 'common sense tells you SCLP is cheap' lol. . And he thinks he understands the market .. . . NO NO you fool ...look at the price trajectory SCLP is over-priced |
Posted at 31/1/2025 19:42 by 2tyke Look inane...first and foremost if you don't think holding SCLP is very risky ....you have NO idea about markets and the actual risks involved.You also need to stop thinking that Scancell holdings and SCLP are inter-changeable.... To understand the market you would need to understand and recognise the points that traders actually buy and sell. You don't understand the significance of flurries of trades and what drives them. You are merely a hindsight observer. One of the many who watch and state. ..'somethings going on'..lol You are a pawn...tossed around in ignorance. If this drops below 7.6p...you'll see what wave fodder you are. |
Posted at 20/12/2024 13:49 by 2tyke You are completely wrong chaps.You need to 'fit' the shorter term trends into the larger trends. They should fit seamlessly. Thus....both Bitcoin and SCLP came into existence as it were all n 2010. SCLP has seen continual lower lows and lower highs. The counter-trend rallies ( which is what they were), fit exactly. It's a long term downtrend ( whatever the company has achieved). Conversely....take a look at the long term chart of the absolute phenomenon that is Bitcoin. We are talking exponential uptrend from the moment it was 'born'. Quite simply the best investment a human could EVER make. And it's on-going. What you've done with SCLP is argue with the market. You thought you knew better ...you didn't. And you certainly don't know better than tykey ! |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
